Director at TechnipFMC (NYSE: FTI) granted 3,259 RSUs

Rhea-AI Filing Summary

OLEARY JOHN C G reported acquisition or exercise transactions in this Form 4 filing.

TechnipFMC plc director John C. G. O’Leary received an equity grant of 3,259 Ordinary Shares through restricted stock units. The units were awarded at no cash cost per share and are scheduled to vest on February 16, 2027. After this award, his directly held Ordinary Shares total 137,685.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

OLEARY JOHN C G

(Last) (First) (Middle)

C/O TECHNIPFMC PLC

HADRIAN HOUSE, WINCOMBLEE ROAD

(Street)

NEWCASTLE UPON TYNE X0 NE6 3PL

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TechnipFMC plc [ FTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/16/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	02/16/2026		A		3,259(1)	A	$0	137,685	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units, each of which represents a contingent right to receive one Ordinary Share, that will vest February 16, 2027.

Remarks:

	/s/ Lisa P. Wang, Attorney-In-Fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did TechnipFMC (FTI) disclose in this Form 4 filing?

TechnipFMC disclosed that director John C. G. O’Leary received a grant of 3,259 restricted stock units, each representing one Ordinary Share, which will vest on February 16, 2027. This is a non-cash equity compensation award.

How many TechnipFMC (FTI) shares were granted to the director?

The director was granted 3,259 restricted stock units tied to TechnipFMC Ordinary Shares. Each unit represents a contingent right to receive one share, subject to vesting conditions, with all units scheduled to vest on February 16, 2027, according to the filing footnote.

Was the TechnipFMC (FTI) share award a purchase or a grant?

The transaction was a grant or award acquisition, not an open-market purchase. The Form 4 classifies it under code "A" for grant, with a price per share of $0.0000, indicating non-cash equity compensation issued to the director.

When will the new TechnipFMC (FTI) restricted stock units vest?

The restricted stock units will vest on February 16, 2027. At that time, each unit will convert into one TechnipFMC Ordinary Share, provided the vesting conditions are satisfied, as described in the footnote to the Form 4 transaction.

How many TechnipFMC (FTI) shares does the director hold after this grant?

Following the grant, John C. G. O’Leary is reported as directly owning 137,685 TechnipFMC Ordinary Shares. This total reflects the position immediately after recording the 3,259-share restricted stock unit award disclosed in the Form 4 filing.

What transaction code is used for the TechnipFMC (FTI) director’s award?

The filing uses transaction code "A," which indicates a grant, award, or other acquisition. This code confirms the shares were received as equity compensation, not bought or sold in the open market, and were awarded at a reported price of $0.0000 per share.